sam® Education for Medical Students and Providers Expands to Massachusetts
Nov 2, 2022
Dr. Rod Walters and Corey Carmody at Merrimack College
Dr. Rod Walters and Corey Carmody at Merrimack College
Corey Carmody is hard at work; as a representative for ZetrOZ Systems, he's returned home, tasked with educating the next generation of trainers at his alma mater — Merrimack College in North Andover, Massachusetts — about the latest innovations in sustained acoustic medicine (sam®). In numerous studies, the wearable, low-intensity ultrasound device has demonstrated the ability to accelerate the healing of soft-tissue injuries and restore function in patients who have sustained such injuries.
Carmody, who also holds a Master's Degree in Biomechanics from Auburn University, is partnering with Dr. Rod Walters, former head athletic trainer for the Atlanta Falcons, author and sports medicine expert. Together, they will host educational sessions at local colleges and universities in Massachusetts to share more about the benefits of wearable ultrasound technology and its positive effects on tissue healing. This fall, first- and second-year master's students in Merrimack's athletic training program will have the opportunity to learn firsthand how they can integrate the technology into patient treatment options.
"Our technology is impacting thousands of lives each day, and we want to continue providing education to students and providers so more patients can benefit," said Dr. George Lewis, founder and CEO of ZetrOZ Systems. "Not only is sam® a cost-effective treatment option, but it also offers results without the need for opioids or other drugs while treating and healing patients up to 40% faster than standard methodologies."
Dr. Rod Walters is a nationally recognized leader in the field of athletic training, with decades of experience working in higher education, as well as a consultant for clients, including the National Football League, the Big 12 Athletic Conference, and Cirque du Soleil. Walters was inducted into the National Athletic Trainers Association Hall of Fame in 2005.
sam® is the only home-use bioregenerative medical device cleared by the U.S. Food & Drug Administration (FDA) for the treatment of select medical indications, most commonly for chronic joint pain of the shoulder, knee and elbow, and the treatment of overuse injuries. More than 50 clinical and scientific studies support its effectiveness in healing injuries, restoring function and returning patients to work and everyday activities.
To learn more, visit zetrozsystems.com.
About ZetrOZ Systems
ZetrOZ Systems is leading healing innovations in sports medicine and developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of +46 patents and is the exclusive manufacturer and developer of sam®, a product line designed for the treatment of acute and chronic musculoskeletal conditions.
Contact Information:
Buse Kayar
[email protected]
Press Release Service by Newswire.com
Original Source: sam® Education for Medical Students and Providers Expands to Massachusetts
More News
For an Experiment in Political Affirmative Action, Look to Taiwan
The island adopted quotas for women running for public office decades before other countries. The upshot? Today, few of them need quotas to get elected.
Elon Musk confirms he is considering merging Tesla and SpaceX
Musk says special committees within both companies have been formed to look at a possible mega-merger.
What is happening to UK prices?
UK inflation rose in September, pushed up by higher petrol and diesel prices.
Why is Elon Musk plotting a mega-merger of SpaceX and Tesla?
Musk says there's "a lot to be gained" by combining the firms in what would be the biggest merger in history.
Watch: 'We don't pay' - lawyer advises how to avoid £45,000 illegal-worker fine
Mohammad Alias Yousaf made his claim to an undercover reporter posing as a mini-mart owner.
The tech helping crack decades-old cold cases
Investigative genetic genealogy can help hunt down criminals but raises worries over privacy.
Netflix Is Great at Making Money. Its Problem Is Keeping Viewers Hooked.
The streaming service reported a 12 percent increase in quarterly revenue, but acknowledged that stagnant viewership, particularly in the U.S. and Canada, was a major concern.
SpaceX Swings to a Profit, as A.I. Business Grows
Elon Musk’s rocket company said its artificial intelligence spending had soared, but revenue more than doubled from its Starlink internet satellite service and A.I. products.
Audit regulator looking into Manchester City accounting
No formal investigation has started, but the regulator is making inquiries into the case.
Britain Is Said to Approve New Gas Drilling in the North Sea
Jackdaw, a natural gas field off the coast of Scotland, would be the first new gas extraction project in the North Sea since a government moratorium in 2024.
Boeing’s Large 737 Max Jet Secures U.S. Approval
After years of delay, the Federal Aviation Administration certified the 737 Max 10, the largest version of Boeing’s most popular plane.
OpenAI CEO Sam Altman wins dismissal of sister's lawsuit
A US district judge dismissed the case after Ann Altman had refused to attend an independent medical examination.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.